| Name | Last modified | Size | Description | |
|---|---|---|---|---|
| Parent Directory | - | |||
| 61807_Mily_Voiceover/ | 2021-02-27 00:43 | - | ||
| 61807_R1_RE (1).docx | 2020-09-12 11:06 | 128K | ||
| 61807_R1_RE (2).docx | 2020-09-12 11:06 | 128K | ||
| 61807_R1_RE.docx | 2020-09-04 22:26 | 128K | ||
| 61807_R1_RE_revised...> | 2020-09-14 17:12 | 128K | ||
| 61807fig01.jpg | 2020-09-09 08:41 | 502K | ||
| 61807fig01large.jpg | 2020-09-09 08:41 | 1.9M | ||
| 61807fig02.jpg | 2020-09-09 08:41 | 254K | ||
| 61807fig02large.jpg | 2020-09-09 08:41 | 1.2M | ||
| 61807fig03.jpg | 2020-09-09 08:41 | 333K | ||
| 61807fig03large.jpg | 2020-09-09 08:42 | 1.3M | ||
| 61807fig03v2.jpg | 2020-09-09 13:26 | 187K | ||
| 61807fig03v2large.jpg | 2020-09-09 13:26 | 882K | ||
| 61807fig03v3.jpg | 2020-09-09 13:07 | 294K | ||
| 61807fig03v4.jpg | 2020-09-09 13:40 | 224K | ||
| 61807fig03v4large.jpg | 2020-09-09 13:40 | 1.1M | ||
| 61807fig04.jpg | 2020-09-09 08:41 | 350K | ||
| 61807fig04large.jpg | 2020-09-09 08:42 | 1.4M | ||
| 61807fig2v2.jpg | 2020-09-16 20:47 | 229K | ||
| 61807fig2v2large.jpg | 2020-09-16 20:47 | 512K | ||
| Author_License_Agree..> | 2020-09-04 22:26 | 2.2M | ||
| Cover letter_S Brigh..> | 2020-09-04 22:26 | 107K | ||
| Figure 1_revised.pdf | 2020-09-04 22:26 | 773K | ||
| Figure 2_S Brighenti..> | 2020-09-04 22:26 | 279K | ||
| Figure 2_S Brighenti..> | 2020-09-12 11:06 | 271K | ||
| Figure 3_200819_upda..> | 2020-09-04 22:26 | 339K | ||
| Figure 4_S Brighenti..> | 2020-09-04 22:26 | 597K | ||
| JoVE61807.pdf | 2020-09-04 22:26 | 7.0M | ||
| JoVE61807.xml | 2020-09-04 22:26 | 15K | ||
| Jove_Author_Comment_..> | 2020-09-12 11:05 | 137K | ||
| Point-by-point reply..> | 2020-09-04 22:26 | 24K | ||
| Table 1_Antibodies f..> | 2020-09-04 22:26 | 19K | ||
| Table 1_Antibodies f..> | 2020-09-14 17:12 | 19K | ||
| Table of Materials.xlsx | 2020-09-04 22:26 | 20K | ||
| jove-protocol-61807-..> | 2020-09-12 11:06 | 1.5M | ||